Evidence map›Paper›PMID 35574908›Full record

ArticleJournal of psychopharmacology (Oxford, England)2022

Elevated C-reactive protein among symptomatic youth with bipolar disorder.

Yi Zou, Anahit Grigorian, Sudhir Karthikeyan, Benjamin I Goldstein

Open access · hybridAbstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yi ZouDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-9288-7275
Anahit GrigorianCentre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Sudhir KarthikeyanCentre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Benjamin I GoldsteinDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Centre for Addiction and Mental Health · CA

Funding

CIHR MOP-119525CIHR MOP-136947
6 · The paper itself

Abstract

RATIONALE AND

objectivesIncreased levels of high-sensitivity C-reactive protein (CRP) are associated with mood symptoms in adults with bipolar disorder (BD). The few studies on this topic in youth with BD have not included controls. We, therefore, examined CRP levels in relation to symptomatic status in youth with and without BD.

methodsParticipants included 154 youth (mean age 17 years; 48 asymptomatic BD, 39 symptomatic BD, 67 healthy controls (HC)). Rank analysis of covariance test examined group differences in CRP, controlling for age and sex. Correlation between CRP and mood symptom severity was examined using Spearman's correlation within the BD group.

resultsThere were significant group differences in CRP levels (

conclusionsCRP levels are elevated among symptomatic youth with BD, partly related to BMI. As elevated BMI is associated with mood symptom burden, prospective studies are warranted to parse the associations among mood symptoms, BMI, and inflammation. Given the proportion of time that youth with BD are symptomatic, present findings raise concern about the long-term impact of elevated CRP on blood vessels, brain, and related clinical outcomes.

Indexed as

Bipolar DisorderAdolescentAffectBody Mass IndexC-Reactive ProteinHumansInflammationC-Reactive Proteinbipolar disorderC-reactive proteinsymptomatologysymptom severityYouth

Identifiers

PMID35574908
PMCPMC9127784
OpenAlexW4280522736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.